RIPK3 and Patent ductus arteriosus: Mechanistically, this was linked to an increased RIPK1/RIPK3-dependent protein product of PDA cells (SAP130), which promoted cellular immune suppression by tumour infiltrating macrophages expressing the protein receptor (Mincle) that were themselves recruited in a CXCL1-dependent manner.